TP53 and Miyoshi myopathy: TP53, CDKN1A, and MDM2 mRNA levels remained unchanged by RAC1 knockdown, reinforcing the notion that the reduction in MM cell survival via Rac1 inhibition is independent of the p53 status (Figure 4A,B).